Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats.

[1]  S. Fagan,et al.  Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence. , 2011, Clinical science.

[2]  U. Laufs,et al.  ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. , 2009, Cardiovascular research.

[3]  T. Yokoi,et al.  Exercise Training Alters Left Ventricular Geometry and Attenuates Heart Failure in Dahl Salt-Sensitive Hypertensive Rats , 2009, Hypertension.

[4]  Hong Wang,et al.  Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats. , 2008, Chinese medical journal.

[5]  K. Okumura,et al.  Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis , 2008, Hypertension.

[6]  J. Norman,et al.  VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. , 2006, Blood.

[7]  T. Kato,et al.  Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats , 2006, Hypertension.

[8]  K. Nagata,et al.  Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. , 2006, Cardiovascular research.

[9]  T. Kato,et al.  Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy: A Pilot Study , 2005, Circulation.

[10]  T. Naoe,et al.  Nicorandil Promotes Myocardial Capillary and Arteriolar Growth in the Failing Heart of Dahl Salt-Sensitive Hypertensive Rats , 2005, Hypertension.

[11]  T. Gustafsson,et al.  Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart. , 2005, American journal of hypertension.

[12]  I. Shiojima,et al.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. , 2005, The Journal of clinical investigation.

[13]  I. Inuwa,et al.  Long-term exercise training and angiotensin-converting enzyme inhibition differentially enhance myocardial capillarization in the spontaneously hypertensive rat , 2005, Journal of hypertension.

[14]  B. Lévy,et al.  Dual Effect of Angiotensin-Converting Enzyme Inhibition on Angiogenesis in Type 1 Diabetic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Hori,et al.  AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart Failure , 2004, Hypertension.

[16]  J. Toblli,et al.  Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. , 2004, American journal of hypertension.

[17]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[18]  Y. Yoshikawa,et al.  Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[19]  S. Miura,et al.  Transactivation of KDR/Flk-1 by the B2 Receptor Induces Tube Formation in Human Coronary Endothelial Cells , 2003, Hypertension.

[20]  H. Izawa,et al.  AT1 Receptor Blockade Reduces Cardiac Calcineurin Activity in Hypertensive Rats , 2002, Hypertension.

[21]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[22]  B. Lévy,et al.  Proangiogenic Effect of Angiotensin-Converting Enzyme Inhibition Is Mediated by the Bradykinin B2 Receptor Pathway , 2001, Circulation research.

[23]  H. Izawa,et al.  Reduced Myocardial Sarcoplasmic Reticulum Ca2+-ATPase mRNA Expression and Biphasic Force-Frequency Relations in Patients With Hypertrophic Cardiomyopathy , 2001, Circulation.

[24]  H. Traxler,et al.  Selective Downregulation of VEGF-A165, VEGF-R1, and Decreased Capillary Density in Patients With Dilative but Not Ischemic Cardiomyopathy , 2000, Circulation research.

[25]  N. Kobayashi,et al.  Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats. , 2000, American journal of hypertension.

[26]  J. Cooke,et al.  Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[28]  D. Levy,et al.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[29]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[30]  C. H. Conrad,et al.  Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. , 1997, Circulation.

[31]  C. Garlanda,et al.  Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.

[32]  R. Busse,et al.  ACE inhibitor potentiation of bradykinin‐induced venoconstriction , 1997, British journal of pharmacology.

[33]  G. B. John Mancini,et al.  Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .

[34]  S Sasayama,et al.  Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. , 1994, The American journal of physiology.

[35]  D. Campbell,et al.  Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. , 1994, Hypertension.

[36]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[37]  R. Tomanek.  Response of the coronary vasculature to myocardial hypertrophy. , 1990, Journal of the American College of Cardiology.

[38]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[39]  I. Komuro,et al.  Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy Roles of Cardiac Transcription Factors in Cardiac Hypertrophy Ras, Akt, and Mechanotransduction in the Cardiac Myocyte G Protein–Coupled Signaling and Gene Expression Genetic Models and Mechanisms of Transcription in Car , 2003 .